ArticleJournal of thrombosis and thrombolysis2019

Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.

Zachary Howe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.